STAT signalling in the heart and cardioprotection

Expert Reviews in Molecular Medicine

Volumn 8, Issue 15, 2006, Pages 1-16

  Soond, Surinder M ^a   Latchman, David S ^a   Stephanou, Anastasis ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CASPASE 3; CASPASE 9; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; JANUS KINASE 1; JANUS KINASE 2; LEUKEMIA INHIBITORY FACTOR; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5A PROTEIN; STAT5B PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNINDEXED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL SURVIVAL; CLINICAL TRIAL; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME INDUCTION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MODELS, BIOLOGICAL; MYOCARDIUM; MYOCYTES, CARDIAC; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33745875981     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399406000032     Document Type: Review

References (117)

1. Yusuf, S. et al. (2001) Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104, 2855-2864
2. McCord, J.M. and Fridovich, I. (1969) The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 244, 6056-6063
3. Bolli, R. et al. (1997) Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81, 42-52
4. Guo, Y. et al. (1999) The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A 96, 11507-11512
5. Shinmura, K. et al. (2000) Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci U S A 97, 10197-10202
6. Latchman, D.S. (2001) Heat shock proteins and cardiac protection. Cardiovasc Res 51, 637-646
7. Yellon, D.M. and Downey, J.M. (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83, 1113-1151
8. Schindler, C. and Darnell, J.E., Jr. (1995) Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Annu Rev Biochem 64, 621-651
9. Kunisada, K. et al. (1996) Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 94, 2626-2632
10. Pan, J. et al. (1997) Role of angiotensin II in activation of the JAK/ STAT pathway induced by acute pressure overload in the rat heart. Circ Res 81, 611-617
11. Chin, Y.E. et al. (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17, 5328-5337
12. Bolli, R., Dawn, B. and Xuan, Y.T. (2001) Emerging role of the JAK-STAT pathway as a mechanism of protection against ischemia/reperfusion injury. J Mol Cell Cardiol 33, 1893-1896
13. Hattori, R. et al. (2001) Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 33, 1929-1936
14. Mascareno, E. et al. (2001) JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104, 325-329
15. Negoro, S. et al. (2000) Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 47, 797-805
16. Omura, T. et al. (2001) Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J Mol Cell Cardiol 33, 307-316
17. Stephanou, A. et al. (2000) Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 275, 10002-10008
18. Xuan, Y.T. et al. (2001) An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A 98, 9050-9055
19. Stephanou, A. (2004) Role of STAT-1 and STAT-3 in ischaemia/reperfusion injury. J Cell Mol Med 8, 519-525
20. Darnell, J.E., Jr. (1997) STATs and gene regulation. Science 277, 1630-1635
21. Imada, K. and Leonard, W. J. (2000) The Jak-STAT pathway. Mol Immunol 37, 1-11
22. Booz, G.W., Day, J.N. and Baker, K.M. (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: Role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34, 1443-1453
23. Levy, D.E. and Darnell, J.E., Jr. (2002) Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651-662
24. Wen, Z., Zhong, Z. and Darnell, J.E., Jr. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250
25. Stephanou, A. et al. (2001) Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 276, 28340-28347
26. Shen, Y. et al. (2004) Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 24, 407-419
27. Rakesh, K. and Agrawal, D.K. (2005) Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol 70, 649-657
28. Ryo, A. et al. (2003) Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12, 1413-1426
29. Shuai, K. and Liu, B. (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3, 900-911
30. Sugano, M. et al. (2005) RNA interference targeting SHP-1 attenuates myocardial infarction in rats. Faseb J 19, 2054-2056
31. Marrero, M.B. et al. (1998) Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: Roles of SHP-1 and SHP-2. Am J Physiol 275, C1216-1223
32. Kaiser, R.A. et al. (2004) Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 279, 15524-15530
33. Melchior, F. (2000) SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 16, 591-626
34. O'Shea, J.J. and Watford, W. (2004) A peek at PIAS. Nat Immunol 5, 875-876
35. Liu, B. et al. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci U S A 95, 10626-10631
36. Chung, C.D. et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805
37. Murry, C.E., Jennings, R.B. and Reimer, K.A. (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136
38. Cohen, M.V., Baines, C.P. and Downey, J.M. (2000) Ischemic preconditioning: From adenosine receptor to KATP channel. Annu Rev Physiol 62, 79-109
39. Bolli, R. (2000) The late phase of preconditioning. Circ Res 87, 972-983
40. Sun, J.Z. et al. (1995) Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest 95, 388-403
41. Yellon, D.M. and Downey, J.M. (2002) Spotlight on preconditioning. Cardiovasc Res 55, 425-428
42. Taggart, P. and Yellon, D.M. (2002) Preconditioning and arrhythmias. Circulation 106, 2999-3001
43. Liu, P.P. and Mason, J.W. (2001) Advances in the understanding of myocarditis. Circulation 104, 1076-1082
44. Baxter, G.F. et al. (2000) Adenosine A1 agonist at reperfusion trial (AART): Results of a three-center, blinded, randomized, controlled experimental infarct study. Cardiovasc Drugs Ther 14, 607-614
45. Bolli, R. (2001) Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: An overview of a decade of research. J Mol Cell Cardiol 33, 1897-1918
46. Becker, L.B. (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61, 461-470
47. Xuan, Y.T. et al. (2000) Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279, H2360-2371
48. Shinmura, K. et al. (2002) COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol 283, H2534-2543
49. Shinmura, K. et al. (2002) Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91, 240-246
50. Hoshida, S. et al. (2002) The importance of manganese superoxide dismutase in delayed preconditioning: Involvement of reactive oxygen species and cytokines. Cardiovasc Res 55, 495-505
51. Prieto-Alamo, M.J. et al. (2000) Transcriptional regulation of glutaredoxin and thioredoxin pathways and related enzymes in response to oxidative stress. J Biol Chem 275, 13398-13405
52. Marber, M.S. et al. (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88, 1264-1272
53. Kitanaka, C. and Kuchino, Y. (1999) Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 6, 508-515
54. Green, D.R. (2000) Apoptotic pathways: Paper wraps stone blunts scissors. Cell 102, 1-4
55. Buja, L.M. (2005) Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 14, 170-175
56. Stephanou, A. and Latchman, D.S. (2003) STAT-1: A novel regulator of apoptosis. Int J Exp Pathol 84, 239-244
57. Xuan, Y.T. et al. (1999) Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 84, 1095-1109
58. Seidel, H.M. et al. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A 92, 3041-3045
59. Horvath, C.M., Wen, Z. and Darnell, J.E., Jr. (1995) A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9, 984-994
60. Xie, Q.W., Whisnant, R. and Nathan, C. (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 177, 1779-1784
61. Yamaura, G. et al. (2003) STAT signaling in ischemic heart: A role of STAT5A in ischemic preconditioning. Am J Physiol Heart Circ Physiol 285, H476-482
62. Smith, R.M. et al. (2004) Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning. Cardiovasc Res 63, 611-616
63. Kunisada, K. et al. (2000) Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A 97, 315-319
64. Stephanou, A. et al. (2000) Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 7, 329-330
65. Janjua, S., Stephanou, A. and Latchman, D.S. (2002) The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ 9, 1140-1146
66. Liao, J.K. (2002) Shedding growth factors in cardiac hypertrophy. Nat Med 8, 20-21
67. Hilfiker-Kleiner, D. et al. (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95, 187-195
68. Gottlieb, R.A. et al. (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94, 1621-1628
69. Kajstura, J. et al. (1996) Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74, 86-107
70. Stephanou, A. et al. (2001) Distinct initiator caspases are required for the induction of apoptosis in cardiac myocytes during ischaemia versus reperfusion injury. Cell Death Differ 8, 434-435
71. Scarabelli, T.M. et al. (2002) Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/ reperfusion injury. Circ Res 90, 745-748
72. King, P. and Goodbourn, S. (1998) STAT1 is inactivated by a caspase. J Biol Chem 273, 8699-8704
73. Meraz, M.A. et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442
74. Durbin, J.E. et al. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450
75. Stephanou, A. et al. (2002) The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. Faseb J 16, 1841-1843
76. Stephanou, A. and Latchman, D.S. (2005) Opposing actions of STAT-1 and STAT-3. Growth Factors 23, 177-182
77. Stephanou, A. (2002) Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. Eur Cytokine Netw 13, 401-403
78. Das, D.K. and Maulik, N. (2003) Preconditioning potentiates redox signaling and converts death signal into survival signal. Arch Biochem Biophys 420, 305-311
79. Grune, T., Reinheckel, T. and Davies, K.J. (1997) Degradation of oxidized proteins in mammalian cells. Faseb J 11, 526-534
80. Kevin, L.G. et al. (2003) Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol 284, H566-574
81. Vanden Hoek, T.L. et al. (1998) Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem 273, 18092-18098
82. Carmody, R.J. and Cotter, T.G. (2001) Signalling apoptosis: A radical approach. Redox Rep 6, 77-90
83. Simon, A.R. et al. (1998) Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275, C1640-1652
84. Dawn, B. et al. (2004) IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64, 61-71
85. Kukielka, G.L. et al. (1995) Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92, 1866-1875
86. Chandrasekar, B. et al. (1999) Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 99, 427-433
87. Gwechenberger, M. et al. (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546-551
88. Latchman, D.S. (2000) Cardiotrophin-1: A novel cytokine and its effects in the heart and other tissues. Pharmacol Ther 85, 29-37
89. Kodama, H. et al. (1997) Leukemia inhibitory factor, a potent cardiac hypertrophy cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 81, 656-663
90. Negoro, S. et al. (2001) Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/ reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 104, 979-981
91. Fukuzawa, J. et al. (2000) Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy. Hypertension 35, 1191-1196
92. Sheng, Z. et al. (1996) Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122, 419-428
93. Sauer, H. et al. (2004) Involvement of reactive oxygen species in cardiotrophin-1-induced proliferation of cardiomyocytes differentiated from murine embryonic stem cells. Exp Cell Res 294, 313-324
94. Stephanou, A. et al. (1998) Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol 30, 849-855
95. Wang, J. et al. (2005) Convergence of protein kinase C and JAK-STAT signaling on transcription factor GATA-4. Mol Cell Biol 25, 9829-9844
96. Irwin, M.W. et al. (1999) Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99, 1492-1498
97. Hoshida, S. et al. (2002) Repeated physiologic stresses provide persistent cardioprotection against ischemia-reperfusion injury in rats. J Am Coll Cardiol 40, 826-831
98. Lecour, S., Rochette, L. and Opie, L. (2005) Free radicals trigger TNF alpha-induced cardioprotection. Cardiovasc Res 65, 239-243
99. Lecour, S. et al. (2005) Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases Akt and extracellular signal-regulated kinase. Circulation 112, 3911-3918
100. Maekawa, N. et al. (2002) Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha. J Am Coll Cardiol 39, 1229-1235
101. Dawn, B. et al. (2004) Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37, 51-61
102. Kurrelmeyer, K.M. et al. (2000) Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97, 5456-5461
103. Ng, D.C., Long, C.S. and Bogoyevitch, M.A. (2001) A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem 276, 29490-29498
104. Harada, M. et al. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11, 305-311
105. Xuan, Y.T. et al. (2003) Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol 35, 525-537
106. Xuan, Y.T. et al. (2005) Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112, 1971-1978
107. Salvemini, D. et al. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90, 7240-7244
108. Altup, S. et al. (2001) Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur J Pharmacol 415, 239-246
109. Townsend, P.A. et al. (2004) Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/ reperfusion-induced apoptosis. Faseb J 18, 1621-1623
110. Guaiquil, V.H. et al. (2004) Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 37, 1419-1429
111. Simkhovich, B.Z. et al. (2003) Brief episode of ischemia activates protective genetic program in rat heart: A gene chip study. Cardiovasc Res 59, 450-459
112. Simkhovich, B.Z. et al. (2003) Gene expression profiling-a new approach in the study of myocardial ischemia. Cardiovasc Pathol 12, 180-185
113. Yamauchi-Takihara, K. et al. (1995) Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91, 1520-1524
114. Yamashita, N. et al. (1999) Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189, 1699-1706
115. Rafiee, P. et al. (2005) Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100, 187-197
116. McWhinney, C.D. et al. (1997) The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol 29, 2513-2524
117. Mascareno, E. and Siddiqui, M.A. (2000) The role of Jak/STAT signaling in heart tissue renin-angiotensin system. Mol Cell Biochem 212, 171-175